Pharmaceutics (Sep 2020)

Phytol-Loaded Solid Lipid Nanoparticles as a Novel Anticandidal Nanobiotechnological Approach

  • Tábata L. C. Lima,
  • Luanda B. F. C. Souza,
  • Lannya C. S. Tavares-Pessoa,
  • Alaine M. dos Santos-Silva,
  • Rômulo S. Cavalcante,
  • Raimundo F. de Araújo-Júnior,
  • Alianda M. Cornélio,
  • Matheus F. Fernandes-Pedrosa,
  • Guilherme Maranhão Chaves,
  • Arnóbio Antônio da Silva-Júnior

DOI
https://doi.org/10.3390/pharmaceutics12090871
Journal volume & issue
Vol. 12, no. 9
p. 871

Abstract

Read online

Phytol is a diterpene alcohol and can be found as a product of the metabolism of chlorophyll in plants. This compound has been explored as a potential antimicrobial agent, but it is insoluble in water. In this study, we describe a novel approach for an interesting anticandidal drug delivery system containing phytol. Different formulations of phytol-loaded solid lipid nanoparticles (SLN) were designed and tested using a natural lipid, 1,3-distearyl-2-oleyl-glycerol (TG1). Different compositions were considered to obtain three formulations with 1:10, 1:5, and 1:3 w/w phytol/TG1 ratios. All the formulations were prepared by emulsification solvent evaporation method and had their physicochemical properties assessed. The biocompatibility assay was performed in the HEK-293 cell line and the antifungal efficacy was demonstrated in different strains of Candida ssp., including different clinical isolates. Spherical and uniform SLN (65% were achieved. Phytol-loaded SLN showed a dose-dependent cytotoxic effect in the HEK-293 cell line. The three tested formulations of phytol-loaded SLN considerably enhanced the minimal inhibitory concentration of phytol against 15 strains of Candida spp. Considering the clinical isolates, the formulations containing the highest phytol/TG1 ratios showed MICs at 100%. Thus, the feasibility and potential of phytol-loaded SLN was demonstrated in vitro, being a promising nanocarrier for phytol delivery from an anticandidal approach.

Keywords